1233 Locust Street
Suite 401
Philadelphia, PA 19107
(215) 955-4068
Suite 401
Philadelphia, PA 19107
(215) 955-4068
Most Recent Peer-reviewed Publications
- Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes
- Buprenorphine for the treatment of the neonatal abstinence syndrome
- Reducing Stress Among Mothers in Drug Treatment: A Description of a Mindfulness Based Parenting Intervention
- Impact of Mindfulness-Based Parenting on Women in Treatment for Opioid Use Disorder
- Neonatal abstinence syndrome: Presentation and treatment considerations
- Neonatal abstinence syndrome: Presentation and treatment considerations
- Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study
- Do maternal opioids reduce neonatal regional brain volumes: A pilot study
- Response to Wouldes and Woodward: Maternal methadone dose during pregnancy and infant clinical outcome
- The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations
- Induction of pregnant women onto opioid-agonist maintenance medication: An analysis of withdrawal symptoms and study retention
- Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes
- A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine
- Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression
- Buprenorphine treatment of opioid-dependent pregnant women: A comprehensive review
- Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication
- Fetal assessment before and after dosing with buprenorphine or methadone
- Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine
- Maternal opioid treatment: Human experimental research (mother)-approach, issues and lessons learned
- Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates